Bevacizumab boosts visual acuity in diabetes patients

04/9/2012 | MedPage Today (free registration)

Patients with diabetic macular edema who received intravitreal bevacizumab shots retained better visual acuity than those who underwent laser photocoagulation, according to a study in the Archives of Ophthalmology. The patients were evaluated one year and two years after the treatments.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA